FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Revance Therapeutics, Inc.: accounts_payable

One fact, its scope and the complete path back to the official record.

Period: as of 2023-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/753337b3-2d47-4256-8453-93f2e1216ea4

Reported value

$12.996M{"amount": 12996000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
accounts_payable
Period
as of 2023-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001479290-23-000072 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:26.423200+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/accounts-payable/2023-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.